A COVID-19 vaccine is set to be put forward for emergency approval in the U.S. in a few weeks.
Its developers, Pfizer and BioNTech, said the vaccine could prevent nine out of 10 people from getting COVID-19.
Phase 3 clinical trials still need to be completed and it might take a while to get approval.
But as Emanuela Campanella reports, there’s the potential for a major logistical challenge ahead of us that we need to prepare for: keeping the vaccine at an ultra-cold minus-80 degree.
For more info, please go to
Subscribe to Global News Channel HERE:
Like Global News on Facebook HERE:
Follow Global News on Twitter HERE:
Follow Global News on Instagram HERE:
#GlobalNews #pfizervaccine
